Hotspur Technologies Receives FDA 510(k) Clearance for First Three Product Lines Based on the Company's Unique Technology

Friday, July 30, 2010 Drug News
Email Print This Page Comment
Font : A-A+

Improve Efficiency of Treatments to Restore Bloodflow in Dialysis Grafts and Blocked Arteries

For more information contact:

Hotspur Contact:

Gwen Watanabe

President & CEO

(650) 969-3150 office



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook